Essential Concepts in the Use of Cancer Immunotherapies in Bladder Cancer

Access Course

 

Essential Concepts in the Use of Cancer Immunotherapies in Bladder Cancer

Drs Rini, Balar, and Plimack look at the role of immunotherapy in 2 patients with advanced bladder cancer.

 

This activity is intended for oncologists, urologists, surgeons, and other healthcare professionals who treat patients with bladder cancer.

 

The goal of this activity is to discuss the recent advances in the use of immunotherapy for bladder cancer

 

 

Approximate Time to Complete: 30 minutes

 

Course Available Beginning: Sep. 22, 2017

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the identification of what line of treatment emerging immune checkpoint inhibitors may be used in patients with bladder cancer
  • Have increased knowledge regarding the way programmed death-ligand 1 status may affect treatment selection and a patient's potential clinical response to immune checkpoint inhibitor
  • Have greater competence related to recognizing evidence-based treatment options in patients with advanced bladder cancer